Key result
Randomized controlled trial methodologies are needed to develop level 1 evidence for minimally invasive colon cancer surgery, as currently only 24% of surgical patients are managed based on it.
This chapter details how randomized controlled trial methodologies facilitate the development of level 1 evidence in support of minimally invasive colon cancer surgery.
Answers are grounded in this paper and cite their sources.
Current evidence insufficient to guide practice; leaves open the need for RCTs to generate level 1 data on minimally invasive colon cancer surgery.
The new paradigm and standard for medicine and surgery is the evidence-based practice for which the randomized controlled trial is fundamental. Despite the early involvement of surgeons in clinical trials, randomized trials testing novel surgical therapies are not common. Indeed, only 24% of surgical patients are managed based on level 1 evidence. This chapter details how randomized controlled trial methodologies facilitate the development of level 1 evidence in support of minimally invasive colon cancer surgery.
No takes yet. Share an insight, caveat, or question.
Nelson et al. (2007) conducted a review in Colon cancer. Minimally invasive colon cancer surgery was evaluated. Randomized controlled trial methodologies are needed to develop level 1 evidence for minimally invasive colon cancer surgery, as currently only 24% of surgical patients are managed based on it.
Synapse has enriched 10 related papers. Consider them for comparative context: